RCM
EBS icon

Rotella Capital Management’s Emergent Biosolutions EBS Stock Holding History

Rotella Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-48,331
Closed -$1.38M – 457
2015
Q3 		$1.38M Buy
+48,331
New +$1.59M 0.44% 32

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Rotella Capital Management's EBS Position: Q4 2015 in Review

Rotella Capital Management sold out of Emergent Biosolutions (EBS) in Q4 2015, closing a stake of 48,331 shares — an estimated $1.38M sold.

Rotella Capital Management first reported a position in EBS in Q3 2015 and held it in 1 quarter. The position peaked at $1.38M in Q3 2015. 205 funds tracked by Wall St. Rank hold EBS as of Q4 2015.

  • Rotella Capital Management reported no remaining Emergent Biosolutions position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 48,331 Emergent Biosolutions shares in Q4 2015, an estimated $1.38M.
  • Rotella Capital Management first reported a position in Emergent Biosolutions in Q3 2015 and held it in 1 quarter.
  • Rotella Capital Management's Emergent Biosolutions position peaked at $1.38M in Q3 2015.
  • 205 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.